224 related articles for article (PubMed ID: 32737300)
21. Co-infection and co-localization of Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus in HIV-associated Kaposi sarcoma: a case report.
Julius P; Kang G; Siyumbwa S; Musumali J; Tso FY; Ngalamika O; Kaile T; Maate F; Moonga P; West JT; Angeletti P; Wood C
Front Cell Infect Microbiol; 2023; 13():1270935. PubMed ID: 37928187
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus infection and variants of Epstein-Barr nuclear antigen-1 in synovial tissues of rheumatoid arthritis.
Masuoka S; Kusunoki N; Takamatsu R; Takahashi H; Tsuchiya K; Kawai S; Nanki T
PLoS One; 2018; 13(12):e0208957. PubMed ID: 30533036
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
24. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus infection and expression in oral lesions.
Raab-Traub N; Webster-Cyriaque J
Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
[TBL] [Abstract][Full Text] [Related]
26. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis.
Blaschke S; Schwarz G; Moneke D; Binder L; Müller G; Reuss-Borst M
J Rheumatol; 2000 Apr; 27(4):866-73. PubMed ID: 10782808
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.
Chen J; Schaller S; Jardetzky TS; Longnecker R
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847853
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Epstein-Barr virus, cytomegalovirus, and Kaposi's sarcoma-associated herpesvirus infections in peripheral blood leukocytes revealed by a multiplex PCR assay.
Nishiwaki M; Fujimuro M; Teishikata Y; Inoue H; Sasajima H; Nakaso K; Nakashima K; Sadanari H; Yamamoto T; Fujiwara Y; Ogawa N; Yokosawa H
J Med Virol; 2006 Dec; 78(12):1635-42. PubMed ID: 17063511
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
[TBL] [Abstract][Full Text] [Related]
31. Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
Pedergnana V; Syx L; Cobat A; Guergnon J; Brice P; Fermé C; Carde P; Hermine O; Le-Pendeven C; Amiel C; Taoufik Y; Alcaïs A; Theodorou I; Besson C; Abel L
PLoS One; 2014; 9(7):e102501. PubMed ID: 25025336
[TBL] [Abstract][Full Text] [Related]
32. Double the Trouble When Herpesviruses Join Hands.
Choi UY; Park A; Jung JU
Cell Host Microbe; 2017 Jul; 22(1):5-7. PubMed ID: 28704653
[TBL] [Abstract][Full Text] [Related]
33. Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.
Wakeham K; Johnston WT; Nalwoga A; Webb EL; Mayanja BN; Miley W; Elliott AM; Whitby D; Newton R
Int J Cancer; 2015 Jun; 136(12):2822-30. PubMed ID: 25395177
[TBL] [Abstract][Full Text] [Related]
34. Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus.
Smith NA; Baresel PC; Jackson CL; Ogolla S; Toko EN; Heit S; Piriou E; Sumba OP; Middeldorp JM; Colborn KL; Rochford R
J Infect Dis; 2019 Feb; 219(6):955-963. PubMed ID: 30312417
[TBL] [Abstract][Full Text] [Related]
35. Infection of KSHV and Interaction with HIV: The Bad Romance.
Qin J; Lu C
Adv Exp Med Biol; 2017; 1018():237-251. PubMed ID: 29052142
[TBL] [Abstract][Full Text] [Related]
36. Multiple sclerosis and Epstein-Barr virus.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
[TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern.
De Paschale M; Agrappi C; Manco MT; Mirri P; Viganò EF; Clerici P
J Med Virol; 2009 Feb; 81(2):325-31. PubMed ID: 19107979
[TBL] [Abstract][Full Text] [Related]
38. Presence of Viral microRNA in Extracellular Environments.
DeMarino C; Kashanchi F
EBioMedicine; 2017 Jun; 20():9-10. PubMed ID: 28495208
[No Abstract] [Full Text] [Related]
39. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
40. [Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].
Yi B; Gu YL; Zong YS; Cheng WM; Ji MF
Ai Zheng; 2009 Aug; 28(8):822-6. PubMed ID: 19664327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
